4 completed, 1 terminated. 3 Phase 1, 3 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Not applicable | 1 | Completed 1 |
Follow Anne Chang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea Secukinumab - Papulopustular Rosacea | Phase 1 / Phase 2 | Completed | Anne Chang | 24 | 2017-06-21 | 2020-02-05 |
| Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers Sirolimus, Metformin, Diclofenac - Aging | Phase 1 | Completed | Anne Chang | 10 | 2017-03-01 | 2019-04-01 |
| Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer Pembrolizumab, Vismodegib - Skin Basal Cell Carcinoma | Phase 1 / Phase 2 | Completed | Anne Chang | 16 | 2016-02-01 | 2019-03-08 |
| Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma Buparlisib, Sonidegib - Carcinoma, Basal Cell, Recurrent Skin Cancer | Phase 2 | Terminated | Anne Chang | 10 | 2015-02-01 | 2019-01-29 |
| Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors LDE225 - Basal Cell Carcinoma | Not applicable | Completed | Anne Chang | 11 | 2012-02-01 | 2017-01-16 |
Carcinoma, Basal Cell (3) · Basal Cell Nevus Syndrome (1) · Rosacea (1) · Skin Neoplasms (1)
sonidegib (2) · Diclofenac (1) · HhAntag691 (1) · Metformin (1) · NVP-BKM120 (1) · Sirolimus (1) · guselkumab (1) · pembrolizumab (1) · secukinumab (1)
United States (5)
Anne Lynn Chang, MD (1) · Anne Lynn S Chang, MD (1)
P30CA124435 (1)